TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Upstream Bio to Participate in Upcoming November Investor Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Meggan Buckwell
Upstream Bio to Participate in Upcoming November Investor Conferences

Upstream Bio, a clinical-stage biotechnology company, will participate in multiple investor conferences in November 2025, presenting its research on verekitug, a potential treatment for inflammatory respiratory diseases.

Insights
UPB   positive

Company is actively presenting at multiple investor conferences, showcasing ongoing clinical development of a novel therapeutic approach for inflammatory respiratory diseases